TFX · Teleflex Inc
$139.67
+1.96 (+1.42%)
At close · Aug 28
Market Cap
$5.92B
Shares
42.37M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.99B
+17.2%
FY2025
Net Income
-$905.64M
-1399.8%
FY2025
Gross Margin
56.24%
-4.8pp
FY2025
Operating Margin
5.94%
-0.2pp
FY2025
Diluted EPS
-$20.25
-1468.2%
FY2025
Operating Cash Flow
$96.68M
-68%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $2.25B | $1.99BG | $1.7B | $1.71BG | $2.79BG | $2.81B | $2.54B | $2.6B | $2.45B | $2.15B | $1.87B | $1.81B | $1.84B | $1.7B | $1.55B | $1.49B | $1.4B | $1.43B | $1.91B | |
| — | $1.02B | $871.96M | $662.16M | $672.33M | $1.26B | $1.26B | $1.21B | $1.19B | $1.15B | $974.5M | $871.83M | $865.29M | $897.4M | $857.33M | $802.78M | $783.75M | $718.88M | $749.34M | $1.11B | |
| — | $1.24B | $1.12B | $1.04B | $1.04B | $1.53B | $1.55B | $1.32B | $1.41B | $1.3B | $1.17B | $996.2M | $944.4M | $942.43M | $838.95M | $748.23M | $708.78M | $678.84M | $685.54M | $801.52M | |
| — | — | 56.24% | 61.04% | 60.74% | 54.86% | 55.15% | 52.22% | 54.29% | 53.21% | 54.6% | 53.33% | 52.19% | 51.22% | 49.46% | 48.24% | 47.49% | 48.57% | 47.78% | 41.92% | |
| — | $182.51M | $144.78M | $109.02M | $113.63M | $153.82M | $130.84M | $119.75M | $113.86M | $106.21M | $84.77M | $58.58M | $52.12M | $61.04M | $65.05M | $56.28M | $48.71M | $42.38M | $36.69M | $32.6M | |
| — | $869.28M | $720.17M | $674.52M | $622.74M | $863.75M | $860.09M | $743.57M | $851.77M | $797.06M | $699.96M | $563.31M | $568.98M | $578.66M | $502.19M | $454.49M | $423.91M | $403.64M | $388.28M | $502.56M | |
| — | $138.93M | $121.66M | $108.78M | $102.62M | $164.09M | $165.6M | $158.69M | $149.97M | $149.49M | $98.77M | $63.49M | $62.38M | $60.93M | $50.61M | $44.26M | $42.63M | $40.77M | $42.64M | $44.44M | |
| — | $205.79M | $177.74M | $161.53M | $148.11M | $230.59M | $237.36M | $227.25M | $218.37M | $214.71M | $160.34M | $128.35M | $125.33M | $127.03M | $107.94M | $94.88M | $96.5M | $89.74M | — | — | |
| — | $38.91M | $24.49M | $9.63M | $4.22M | $18.8M | $15M | $17.1M | $15.24M | $60.12M | $14.79M | $15.87M | $7.82M | $17.87M | $27.61M | — | $461K | $2.88M | $7.03M | — | |
| — | $44.44M | $118.37M | $103.65M | $258.73M | $499.73M | $628.1M | $423.07M | $427.25M | $321.7M | $372.28M | $319.45M | $315.89M | $284.86M | $233.26M | -$97.38M | $229.57M | $230.29M | $250.23M | $238.96M | |
| — | — | 5.94% | 6.1% | 15.11% | 17.9% | 22.36% | 16.67% | 16.46% | 13.14% | 17.35% | 17.1% | 17.46% | 15.48% | 13.75% | -6.28% | 15.38% | 16.48% | 17.44% | 12.5% | |
| — | $250.24M | $296.11M | $265.19M | $406.83M | $730.32M | $865.46M | $650.32M | $645.62M | $536.42M | $532.62M | $447.8M | $441.23M | $411.89M | $341.2M | -$2.49M | $326.07M | $320.03M | — | — | |
| — | $113.65M | $100.22M | $83.51M | $85.08M | $54.26M | $56.97M | $66.49M | $80.27M | $103.02M | $82.55M | $54.94M | $61.32M | $65.46M | $56.91M | $69.57M | $70.32M | $79.79M | $89.14M | $121.59M | |
| — | $6.81M | $6.4M | $6.15M | $11.68M | $912K | $1.33M | $1.16M | $1.74M | $944K | $771K | $474K | $532K | $706K | $624K | $1.57M | $1.26M | $719K | $2.48M | $2.27M | |
| — | -$63.55M | $24.55M | $26.29M | $185.39M | $445.92M | $559.47M | $357.73M | $339.9M | $219.63M | $284.91M | $245.73M | $244.65M | $220.11M | $175.73M | -$165.37M | $145.1M | $104.59M | $163.57M | $119.64M | |
| — | -$38.5M | -$33.98M | -$30.9M | $41.87M | $83M | $74.35M | $21.93M | -$122.08M | $23.2M | $129.65M | $8.07M | $7.84M | $28.65M | $23.55M | $16.41M | $25.78M | $16.92M | $36.98M | $37.93M | |
| — | -$1.03B | -$905.64M | $69.68M | $356.33M | $363.14M | $485.37M | $335.32M | $461.47M | $200.8M | $152.53M | $237.38M | $244.86M | $187.68M | $150.88M | -$190.06M | $323.33M | $201.09M | $302.99M | $119.77M | |
| — | — | -45.45% | 4.1% | 20.81% | 13.01% | 17.28% | 13.22% | 17.78% | 8.2% | 7.11% | 12.71% | 13.53% | 10.2% | 8.89% | -12.25% | 21.66% | 14.39% | 21.12% | 6.26% | |
| — | — | — | — | $445.45M | $306.58M | $435.71M | $382.42M | $458.16M | $124.81M | $326.16M | $170.62M | $134.63M | $37.64M | $172.07M | -$162.75M | $215.86M | $183.33M | — | — | |
| USD/shares | — | -$23.28 | -$20.30 | $1.49 | $7.58 | $7.74 | $10.38 | $7.21 | $9.99 | $4.39 | $3.39 | $5.48 | $5.89 | $4.54 | $3.67 | -$4.65 | $7.98 | $5.04 | $7.63 | $3.03 |
| USD/shares | $2.54 – $2.84 | -$23.29 | -$20.25G | $1.48G | $7.53G | $7.68G | $10.23 | $7.09 | $9.80 | $4.29 | $3.27 | $4.98 | $5.10 | $4.04 | $3.45 | -$4.65 | $7.92 | $4.99 | $7.59 | $3.01 |
| shares | — | — | 44.62M | 46.84M | 46.98M | 46.9M | 46.77M | 46.49M | 46.2M | 45.69M | 45M | 43.33M | 41.56M | 41.37M | 41.11M | 40.86M | 40.5M | 39.91M | 39.72M | 39.58M |
| shares | — | — | 44.72M | 47.09M | 47.3M | 47.31M | 47.43M | 47.29M | 47.09M | 46.8M | 46.66M | 47.65M | 48.06M | 46.47M | 43.69M | 40.86M | 40.8M | 40.28M | 39.94M | 39.83M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2008–FY2025: $500M in buybacks, $1.06B in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
3.74×
Peer median 3.01×
EV/EBIT
189.60×
Peer median 32.54×
P/E (TTM)
—
Peer median 36.85×
Peer medians compare against the 25 similar-size Medical Instruments & Supplies companies (of 45 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Americas Segment | $1,279,197,000 | $1,156,946,000 | $1,180,709,000 | $1,926,348,000 | $1,659,309,000 | $1,465,035,000 | $1,492,274,000 | $1,351,699,000 |
| EMEA Segment | $472,411,000 | $340,255,000 | $316,972,000 | $558,373,000 | $606,807,000 | $584,859,000 | $588,043,000 | $603,813,000 |
| Asia Segment | $241,105,000 | $202,345,000 | $214,760,000 | $306,320,000 | $297,766,000 | $267,016,000 | $294,328,000 | $286,895,000 |
| Oem | — | — | — | — | $245,681,000 | $220,246,000 | $220,717,000 | $205,976,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States | $1,181,817,000 | $1,079,343,000 | $1,106,896,000 | $1,786,467,000 | $1,769,488,000 | $1,567,144,000 | $1,606,248,000 | $1,449,426,000 |
| Europe | $484,734,000 | $347,899,000 | $330,065,000 | $622,343,000 | $665,000,000 | $646,577,000 | $652,069,000 | $671,264,000 |
| Asia And Asia Pacific | $218,029,000 | $179,567,000 | $187,946,000 | $270,749,000 | $263,022,000 | $230,267,000 | $241,278,000 | $234,090,000 |
| All Other | $108,133,000 | $92,737,000 | $87,534,000 | $111,482,000 | $112,053,000 | $93,168,000 | $95,767,000 | $93,603,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Vascular Access | $917,731,000 | $903,512,000 | $841,114,000 | $683,612,000 | $700,240,000 | $657,703,000 | $600,874,000 | $575,327,000 |
| Interventional | $647,792,000 | $397,340,000 | $407,251,000 | $445,018,000 | $427,500,000 | $382,435,000 | $427,563,000 | $395,423,000 |
| Surgical | $418,155,000 | $404,869,000 | $388,325,000 | $392,917,000 | $377,756,000 | $317,200,000 | $370,074,000 | $358,707,000 |
| Other | $9,035,000 | -$6,175,000 | $75,751,000 | $285,148,000 | $336,585,000 | $367,257,000 | $347,272,000 | $366,845,000 |
| Anesthesia | — | — | — | $388,890,000 | $380,140,000 | $302,293,000 | $338,413,000 | $349,370,000 |
| Interventional Urology | — | — | — | $322,832,000 | $341,661,000 | $290,022,000 | $290,449,000 | $196,735,000 |
| Oem | — | — | — | $272,624,000 | $245,681,000 | $220,246,000 | $220,717,000 | $205,976,000 |
Key facts
CIK
96943
CUSIP
879369106
13F (30d)
306 filings
294 filers
Visit website
Investor relations